ENLV icon

Enlivex Therapeutics
ENLV

Overview Fund Trends Analyst Outlook Journalist POV

16 hedge funds and large institutions have $409K invested in Enlivex Therapeutics in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

Holders
16
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$48K
Puts
$8K
Net Calls
Net Calls Change

Top Buyers

1
+$3.47K
2
+$482
3
+$2

Top Sellers

1
-$33K
2
-$29.7K
3
-$27K
4
SIGI
Susquehanna International Group (Ireland)
Ireland
-$4.37K
5
Group One Trading
Group One Trading
Illinois
-$2.89K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$104K
2
$93K
3
$69.8K
4
$59.5K
5
$20.5K
6
$19.5K
7
$16.5K
8
$14K
9
$4.74K
10
$2K
11
$1.9K
12
$1.32K
13
$1.09K
14
$632
15
$237
16
$2
17
–
18
–
19
–
20
–